Medpace Holdings Inc MEDP reported first-quarter monetary outcomes after market shut on Monday. Right here’s a have a look at the important thing metrics from the quarter.
- Q1 Income: $558.57 million, versus estimates of $527.15 million
- Q1 EPS: $3.67, versus estimates of $3.06
Whole income was up 9.3% on a year-over-year foundation. New enterprise awards totaled $500 million within the quarter, down 18.8% year-over-year. The corporate ended the interval with a backlog of roughly $2.85 billion, down 2.1% year-over-year.
Medpace generated $125.8 million in money move from operations through the quarter. The corporate mentioned it repurchased roughly 1.19 million shares for $389.8 million within the first quarter. Medpace’s board additionally approved a $1 billion improve to the corporate’s buyback, bringing the whole authorization as much as roughly $1.34 billion.
The corporate ended the quarter with $441.4 million in money and money equivalents.
Outlook: Medpace expects full-year 2025 income to be between $2.14 billion and $2.24 billion versus estimates of $2.15 billion. The corporate anticipates full-year earnings of $12.26 to $13.04 per share versus estimates of $12.27 per share.
Medpace executives will additional focus on the quarter on a name with traders and analysts Tuesday morning at 9 a.m. ET.
MEDP Worth Motion: Medpace shares had been down 9.34% after-hours, buying and selling at $262 on the time of publication Monday, in response to Benzinga Pro.
Test This Out:
• Calix Inventory Jumps On Sturdy Q1 Earnings, $100 Million Buyback Enhance
Photograph: mariakray/Shutterstock.
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
